Sports News | Bol: Doping Suspension Lifted After Samples Didn't Match
Get latest articles and stories on Sports at LatestLY. Olympic 800-meter finalist Peter Bol on Tuesday said his provisional doping suspension has been lifted after the A and B samples didn't match.
Sydney, Feb 14 (AP) Olympic 800-meter finalist Peter Bol on Tuesday said his provisional doping suspension has been lifted after the A and B samples didn't match.
Usually testing of the B sample confirms the original adverse finding in doping cases.
“I was just informed that my B sample did not match my A sample,” Bol posted on Twitter.
“My provisional suspension has been lifted by Sport Integrity Australia.”
Sport Integrity Australia later confirmed testing of the B sample by a World Anti-Doping Agency-accredited laboratory showed an atypical finding, but that in itself is not the same as a negative test result.
“The investigation into the matter remains ongoing. Sport Integrity Australia will, as part of its investigation, proceed to consider whether any anti-doping rule violations have been committed,” the government-backed agency said in a statement.
“It is not possible to provide a timeframe at this point.”
Bol repeated Tuesday that he's never taken banned performance-enhancing substances and he described the last month as a “nightmare.”
Athletics Australia announced last month that Bol had failed an out-of-competition test on Oct. 11. The 28-year-old runner's A sample tested positive to the banned drug erythropoietin, known as EPO.
“The relief I am feeling is hard to describe.” Bol said after the B sample results returned.
“The last month has been nothing less than a nightmare. I wish that the results of my A sample had not been leaked, but there is nothing I can do about that.
“To say it one more time: I am innocent and have not taken this substance as I was accused."
Bol placed fourth in the 800-meter final at the Tokyo Olympics and was a silver medalist at the 2022 Commonwealth Games.
Richard Ings, the former head of Australia's anti-doping agency, described the differing results from A and B samples as “exceedingly rare.”
“Questions need asking of the lab and how it processed and assessed the A sample," “Ings posted on Twitter. (AP)
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)